These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 31396087)

  • 1. Palmitoylethanolamide (PEA) as a Potential Therapeutic Agent in Alzheimer's Disease.
    Beggiato S; Tomasini MC; Ferraro L
    Front Pharmacol; 2019; 10():821. PubMed ID: 31396087
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic Oral Palmitoylethanolamide Administration Rescues Cognitive Deficit and Reduces Neuroinflammation, Oxidative Stress, and Glutamate Levels in A Transgenic Murine Model of Alzheimer's Disease.
    Beggiato S; Tomasini MC; Cassano T; Ferraro L
    J Clin Med; 2020 Feb; 9(2):. PubMed ID: 32033363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Palmitoylethanolamide on Neurodegenerative Diseases: A Review from Rodents to Humans.
    Landolfo E; Cutuli D; Petrosini L; Caltagirone C
    Biomolecules; 2022 May; 12(5):. PubMed ID: 35625595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Update of Palmitoylethanolamide and Luteolin Effects in Preclinical and Clinical Studies of Neuroinflammatory Events.
    Cordaro M; Cuzzocrea S; Crupi R
    Antioxidants (Basel); 2020 Mar; 9(3):. PubMed ID: 32150935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution.
    Skaper SD; Facci L; Barbierato M; Zusso M; Bruschetta G; Impellizzeri D; Cuzzocrea S; Giusti P
    Mol Neurobiol; 2015 Oct; 52(2):1034-42. PubMed ID: 26055231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The neuroprotective effects of micronized PEA (PEA-m) formulation on diabetic peripheral neuropathy in mice.
    Impellizzeri D; Peritore AF; Cordaro M; Gugliandolo E; Siracusa R; Crupi R; D'Amico R; Fusco R; Evangelista M; Cuzzocrea S; Di Paola R
    FASEB J; 2019 Oct; 33(10):11364-11380. PubMed ID: 31344333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultramicronized Palmitoylethanolamide (um-PEA): A New Possible Adjuvant Treatment in COVID-19 patients.
    Noce A; Albanese M; Marrone G; Di Lauro M; Pietroboni Zaitseva A; Palazzetti D; Guerriero C; Paolino A; Pizzenti G; Di Daniele F; Romani A; D'Agostini C; Magrini A; Mercuri NB; Di Daniele N
    Pharmaceuticals (Basel); 2021 Apr; 14(4):. PubMed ID: 33917573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations.
    Petrosino S; Di Marzo V
    Br J Pharmacol; 2017 Jun; 174(11):1349-1365. PubMed ID: 27539936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palmitoylethanolamide, a Special Food for Medical Purposes, in the Treatment of Chronic Pain: A Pooled Data Meta-analysis.
    Paladini A; Fusco M; Cenacchi T; Schievano C; Piroli A; Varrassi G
    Pain Physician; 2016 Feb; 19(2):11-24. PubMed ID: 26815246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral Palmitoylethanolamide Treatment Is Associated with Reduced Cutaneous Adverse Effects of Interferon-β1a and Circulating Proinflammatory Cytokines in Relapsing-Remitting Multiple Sclerosis.
    Orefice NS; Alhouayek M; Carotenuto A; Montella S; Barbato F; Comelli A; Calignano A; Muccioli GG; Orefice G
    Neurotherapeutics; 2016 Apr; 13(2):428-38. PubMed ID: 26857391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic effect of palmitoylethanolamide in cognitive decline: A systematic review and preliminary meta-analysis of preclinical and clinical evidence.
    Colizzi M; Bortoletto R; Colli C; Bonomo E; Pagliaro D; Maso E; Di Gennaro G; Balestrieri M
    Front Psychiatry; 2022; 13():1038122. PubMed ID: 36387000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential Effects of Palmitoylethanolamide against Amyloid-β Induced Toxicity in Cortical Neuronal and Astrocytic Primary Cultures from Wild-Type and 3xTg-AD Mice.
    Tomasini MC; Borelli AC; Beggiato S; Ferraro L; Cassano T; Tanganelli S; Antonelli T
    J Alzheimers Dis; 2015; 46(2):407-21. PubMed ID: 25765918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral Ultramicronized Palmitoylethanolamide: Plasma and Tissue Levels and Spinal Anti-hyperalgesic Effect.
    Petrosino S; Cordaro M; Verde R; Schiano Moriello A; Marcolongo G; Schievano C; Siracusa R; Piscitelli F; Peritore AF; Crupi R; Impellizzeri D; Esposito E; Cuzzocrea S; Di Marzo V
    Front Pharmacol; 2018; 9():249. PubMed ID: 29615912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-ultramicronized Palmitoylethanolamide/Luteolin in the Treatment of Cerebral Ischemia: from Rodent to Man.
    Caltagirone C; Cisari C; Schievano C; Di Paola R; Cordaro M; Bruschetta G; Esposito E; Cuzzocrea S;
    Transl Stroke Res; 2016 Feb; 7(1):54-69. PubMed ID: 26706245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Astrocytic palmitoylethanolamide pre-exposure exerts neuroprotective effects in astrocyte-neuron co-cultures from a triple transgenic mouse model of Alzheimer's disease.
    Beggiato S; Cassano T; Ferraro L; Tomasini MC
    Life Sci; 2020 Sep; 257():118037. PubMed ID: 32622942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palmitoylethanolamide in Fibromyalgia: Results from Prospective and Retrospective Observational Studies.
    Del Giorno R; Skaper S; Paladini A; Varrassi G; Coaccioli S
    Pain Ther; 2015 Dec; 4(2):169-78. PubMed ID: 26334329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial Effects of Co-Ultramicronized Palmitoylethanolamide/Luteolin in a Mouse Model of Autism and in a Case Report of Autism.
    Bertolino B; Crupi R; Impellizzeri D; Bruschetta G; Cordaro M; Siracusa R; Esposito E; Cuzzocrea S
    CNS Neurosci Ther; 2017 Jan; 23(1):87-98. PubMed ID: 27701827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palmitoylethanolamide Counteracts Enteric Inflammation and Bowel Motor Dysfunctions in a Mouse Model of Alzheimer's Disease.
    D'Antongiovanni V; Pellegrini C; Antonioli L; Benvenuti L; Di Salvo C; Flori L; Piccarducci R; Daniele S; Martelli A; Calderone V; Martini C; Fornai M
    Front Pharmacol; 2021; 12():748021. PubMed ID: 34658885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palmitoylethanolamide Dampens Reactive Astrogliosis and Improves Neuronal Trophic Support in a Triple Transgenic Model of Alzheimer's Disease:
    Bronzuoli MR; Facchinetti R; Steardo L; Romano A; Stecca C; Passarella S; Steardo L; Cassano T; Scuderi C
    Oxid Med Cell Longev; 2018; 2018():4720532. PubMed ID: 29576849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-ultramicronized Palmitoylethanolamide/Luteolin Promotes the Maturation of Oligodendrocyte Precursor Cells.
    Barbierato M; Facci L; Marinelli C; Zusso M; Argentini C; Skaper SD; Giusti P
    Sci Rep; 2015 Nov; 5():16676. PubMed ID: 26578323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.